See the raw experimental evidence behind an author's publications and reproducibility signals.
Press Enter β΅ to solve
Fuel Your Discoveries
"The finding of the double helix thus brought us not only joy but great relief. It was unbelievably interesting and immediately allowed us to make a serious proposal for the mechanism of gene duplication."
- James Watson
Quick Explanation
Copied
Di Wu β scientific strength snapshot
Strength: strong representation in mechanistic life-science work and quantitative methods, including computational statistics for omics (e.g., limma), immunology, viral biophysics, structural biology, and multi-omics.
Key uncertainty: the provided evidence mixes (i) high-confidence mechanistic biomed papers with (ii) other non-biological/ML/engineering items; without the full publication record, itβs hard to quantify biological rigor across the whole career.
Long Explanation
Author Review (Science-focused): Di Wu
Skeptical, evidence-based critique grounded in the provided raw-paper excerpts + DOIs.
Note: This radar uses the provided excerpt-level scores in the prompt (not an external bibliometric). For a more defensible assessment, youβd need the full methods/results sections for each item.
2) Evidence base & scope caveat
The material provided here includes multiple biomedical papers with DOIs (e.g., omics methods, immunology, primate developmental mechanisms, viral nucleocapsid biophysics, proteostasis/ubiquitin recognition) plus several non-biological/engineering/ML items. Because the full publication record and author-specific contribution signals (first/last/solo, co-first, experimental vs computational lead) are not fully disambiguated, any career-wide βrigorβ score would be uncertain. The critique below therefore focuses on the scientific strength observable in the provided items.
3) βWhat Di Wu shows up inβ (from provided paper list)
This diagram reflects only whatβs explicitly present in the prompt list.
4) Evidence-pillar density (mechanistic triangulation check)
Pillars are computed from the promptβs extracted methods/results descriptions (e.g., perturbation + sequencing + binding + structural inference). Itβs not a standardized scoring rubric.
The author is listed on highly influential computational methods for differential expression and gene set testing, including limma (very high community adoption) and gene-set testing methods like ROAST and competitive gene set tests such as Camera. These works strongly suggest training in statistical rigor and practical handling of complex experimental designs (e.g., βsmall sample sizeβ information borrowing is explicitly highlighted in the limma description).
5.2 Mechanistic biomed work shows βtriangulationβ across perturbation + readout + modeling
Several provided biomedical items describe multi-level evidence chains:
Primate-specific Alu editing control: ILF2/3 is described as binding Alu-containing transcripts and inhibiting ADAR1-mediated A-to-I editing to protect chromatin regulator transcripts and enable primate cell fate transitions, with cross-species comparisons to mouse suggesting primate specificity.
Viral nucleocapsid fuzzy assembly: multiple interface classes and oligomerization outcomes are tied to biophysical measurements (e.g., SV-AUC, mass photometry, VLP assays) plus structural inference; the extracted mechanism emphasizes multi-weak-interaction networks that shift RNP assembly size/stability and correlate with packaging/infectivity changes.
Proteasome branched ubiquitin recognition: cryo-EM + XL-MS + quantitative ubiquitin chain analysis + cellular perturbation (PSMD1 edits) are described as converging on an RPN2-based multivalent binding groove that coordinates branched K11/K48 linkages and couples to gate opening/substrate processing.
T cell signaling condensates: CD28 phase separation with Lck is described, with PD-1 phosphorylation acting to dissolve condensates; condensation-selective CD28 mutants are proposed to resist PD-1 disruption and improve CAR-T functional readouts in vitro/in vivo models.
For computational biology, the provided repurposing paper integrates TCGA multi-omics (HPV-stratified) with network expansion and PubMed/LLM literature validation, then maps to DrugBank and uses enrichment testing with multiple hypothesis correction.
For image-based bioinformatics, DNAsight is described as base-pair-calibrated segmentation/quantification for AFM chromatin imaging using a U-Net-like architecture with protein/DNA segmentation modules and quantification modules.
6) Scientific blindspots & why skepticism is warranted
6.1 In silico / in vitro βchain-of-causalityβ risks
Repurposing pipelines can over-rank widely studied drugs/genes due to biases in PubMed and DrugBank coverage; the provided repurposing excerpt explicitly lists limitations including computational prediction needing experimental validation and potential literature-mining biases.
Structural biology with disordered proteins (e.g., βfuzzyβ nucleocapsid assembly) faces interpretability issues because disorder/heterogeneity can limit a single structural narrative; the provided fuzzy RNP excerpt flags uncertainty about physiological covalent bonds and the extent to which in vitro/VLP settings reflect in vivo assembly dynamics.
6.2 Cross-species extrapolation needs especially careful controls
ILF2/3 primate specificity relies on cross-species comparisons using in vitro/primate-derived models; such comparisons can be confounded by differentiation state, culture conditions, and assay sensitivity. The excerpt explicitly frames this as a blindspot/limitation.
The supplied list includes topics outside classic molecular biology (e.g., object detection loss functions, fuzzy R&D in materials). Without an author-identity resolver and author-contribution mapping, itβs possible that the name βDi Wuβ aggregates multiple researchers. The scientific review above therefore cannot safely infer that every listed item is from a single biological-research persona; it only evaluates what is evident from the provided DOIs and summaries.
7) Bottom line (with confidence boundaries)
High-confidence: In the provided biomedical evidence set, the work repeatedly shows mechanistic coupling (perturbation β molecular readout β functional inference), especially in primate-specific RNA editing mechanisms (), viral nucleocapsid assembly ( ), and proteasome recognition of branched ubiquitin ( ).
Moderate-confidence: Methodological credibility is suggested by involvement in widely adopted omics/statistical tools (), but the prompt doesnβt provide author-level contribution granularity for every item.
Low-confidence / unknown: Any statement about author-wide biological rigor across all career outputs is underdetermined because the evidence here mixes topics and may include name-identity aggregation risk.
Explore deeper in BGPT
Feedback:
Updated: April 05, 2026
BGPT Author Review
Scientific Quality
70%
Across the provided evidence, Di Wuβs scientific footprint appears strongest where mechanistic coupling and quantitative methods are prominent (omics statistics via widely used methods; mechanistic biophysics/structural biology/immunology with multi-modal readouts). However, the evidence here is heterogeneous (including engineering/ML/materials) and the prompt doesnβt disambiguate author identity or contributions across all items, limiting certainty about overall biological rigor. Potential blindspots include over-reliance on in vitro/in silico links to in vivo mechanisms and cross-species extrapolation without exhaustive orthogonal validation.
Communication Quality
60%
Based on excerpt summaries, the work tends to communicate mechanisms and experimental pipelines, but the prompt does not include Di Wu-authored narrative text or full-method clarity, so communication quality canβt be evaluated directly. The summaries are sometimes dense and require inference from extracted methods/results rather than transparent author-style explanation.
Author Novelty
70%
Several provided items describe novel mechanistic claims (e.g., primate-specific ILF2/3βAlu editing control; multivalent branched-ubiquitin recognition groove in the 26S proteasome; fuzzy RNP interface network models). Other items are more incremental (e.g., pipelines/segmentation frameworks). Without full coverage, novelty across the whole output is uncertain.
Scientific Rigor
70%
Rigor looks strongest where multiple evidence modalities are combined and limitations are acknowledged (e.g., cryo-EM + XL-MS + perturbations in proteasome work; multi-assay biophysics + functional assays in viral nucleocapsid work; triangulation in condensate signaling and AFM segmentation). Yet several summaries flag remaining uncertainties (in vitro/in silico translation; disorder/heterogeneity; cross-species differences), which reduces the effective rigor-to-conclusion confidence for causal claims.
No single bioinformatics code path can be executed from the provided prompt because no raw sequencing/proteomics matrices are included; itβs mostly mechanistic review, not analyzable datasets.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
The simple hypothesis that βmore stable nucleocapsid RNPs always increases viral fitnessβ is weakened by the need for mutation-specific pathways and multi-factor in vivo effects noted in the fuzzy RNP context.
A strongman hypothesis that βone universal primate mechanism dominates developmentβ is weakened by the complexity of lineage specification and the reliance on in vitro/primate model comparisons in the ILF2/3βAlu excerpt.
Quick Explanation
Long Explanation
Top Data Sources
ExportMCP
Analysis Wizard
Hypothesis Graveyard
Potential Experiments
Discussion
Fuel Your Discoveries
Ask a Follow-Up
Key Insight
Keep Exploring
